Guillermo Tortolero-Luna to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Guillermo Tortolero-Luna has written about Uterine Cervical Neoplasms.
Connection Strength
3.021
-
Col?n-L?pez V, V?lez-Alamo C, Medina-Cort?s L, Soto-Salgado M, Ayala-Mar?n A, Acevedo-Fontanez AI, Rivera-Irizarry AM, S?nchez-Aracil M, Salgado-Cruz O, Tortolero-Luna G. The Puerto Rico Community Cancer Control Outreach Program: Developing Capacity-Building Activities on Cancer Screening Guidelines and HPV Vaccination Recommendations for Health Care Professionals. P R Health Sci J. 2022 12; 41(4):217-221.
Score: 0.710
-
Ortiz AP, Soto-Salgado M, Calo WA, Hull P, Fern?ndez ME, Colon-L?pez V, Tortolero-Luna G. Elimination of cervical cancer in U.S. Hispanic populations: Puerto Rico as a case study. Prev Med. 2021 03; 144:106336.
Score: 0.629
-
Ortiz AP, Hebl S, Serrano R, Fernandez ME, Su?rez E, Tortolero-Luna G. Factors associated with cervical cancer screening in Puerto Rico. Prev Chronic Dis. 2010 May; 7(3):A58.
Score: 0.296
-
Tortolero-Luna G. A case-control study of human papillomavirus and cervical squamous intraepithelial lesions (SIL) in Harris County, Texas: differences among racial/ethnic groups. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S207-8.
Score: 0.218
-
Gopalani SV, Soman A, Shapiro JA, Miller JW, Ortiz-Ortiz KJ, Casta?eda-Avila MA, Buenconsejo-Lum LE, Fredericks LE, Tortolero-Luna G, Saraiya M. Breast, cervical, and colorectal cancer screening test use in the US territories of Guam, Puerto Rico, and the US Virgin Islands. Cancer Epidemiol. 2023 06; 84:102371.
Score: 0.182
-
Ortiz AP, Ortiz-Ortiz KJ, Col?n-L?pez V, Tortolero-Luna G, Torres-Cintr?n CR, Wu CF, Deshmukh AA. Incidence of Cervical Cancer in Puerto Rico, 2001-2017. JAMA Oncol. 2021 03 01; 7(3):456-458.
Score: 0.157
-
M?ndez K, Romaguera J, P?rez CM, Soto-Salgado M, Tortolero-Luna G, Palefsky JM, Ortiz AP. Cervical human papillomavirus infection in a sample of Hispanic women living in Puerto Rico: comparison with cervical cytology reports. P R Health Sci J. 2013 Mar; 32(1):3-7.
Score: 0.090
-
Fern?ndez ME, Gonzales A, Tortolero-Luna G, Williams J, Saavedra-Embesi M, Chan W, Vernon SW. Effectiveness of Cultivando la Salud: a breast and cervical cancer screening promotion program for low-income Hispanic women. Am J Public Health. 2009 May; 99(5):936-43.
Score: 0.069
-
Fern?ndez ME, Diamond PM, Rakowski W, Gonzales A, Tortolero-Luna G, Williams J, Morales-Campos DY. Development and validation of a cervical cancer screening self-efficacy scale for low-income Mexican American women. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):866-75.
Score: 0.068
-
Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Mu?oz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008 Aug 19; 26 Suppl 10:K1-16.
Score: 0.066
-
Scheurer ME, Guillaud M, Tortolero-Luna G, McAulay C, Follen M, Adler-Storthz K. Human papillomavirus-related cellular changes measured by cytometric analysis of DNA ploidy and chromatin texture. Cytometry B Clin Cytom. 2007 Sep; 72(5):324-31.
Score: 0.062
-
Eggleston KS, Coker AL, Williams M, Tortolero-Luna G, Martin JB, Tortolero SR. Cervical cancer survival by socioeconomic status, race/ethnicity, and place of residence in Texas, 1995-2001. J Womens Health (Larchmt). 2006 Oct; 15(8):941-51.
Score: 0.058
-
Ramondetta LM, Sun C, Hollier L, Jarrett L, Folloder J, Tortolero-Luna G, Hughes A, Jhingran A, Brown J. Advanced cervical cancer treatment in Harris County: pilot evaluation of factors that prevent optimal therapy. Gynecol Oncol. 2006 Nov; 103(2):547-53.
Score: 0.057
-
Bierl C, Karem K, Poon AC, Swan D, Tortolero-Luna G, Follen M, Wideroff L, Unger ER, Reeves WC. Correlates of cervical mucosal antibodies to human papillomavirus 16: results from a case control study. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S262-8.
Score: 0.054
-
Fern?ndez ME, Gonzales A, Tortolero-Luna G, Partida S, Bartholomew LK. Using intervention mapping to develop a breast and cervical cancer screening program for Hispanic farmworkers: Cultivando La Salud. Health Promot Pract. 2005 Oct; 6(4):394-404.
Score: 0.054
-
Sarkar AK, Tortolero-Luna G, Follen M, Sastry KJ. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S251-61.
Score: 0.054
-
Swan DC, Rajeevan M, Tortolero-Luna G, Follen M, Tucker RA, Unger ER. Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol. 2005 Mar; 96(3):695-700.
Score: 0.052
-
Ho V, Yamal JM, Atkinson EN, Basen-Engquist K, Tortolero-Luna G, Follen M. Predictors of breast and cervical screening in Vietnamese women in Harris County, Houston, Texas. Cancer Nurs. 2005 Mar-Apr; 28(2):119-29; quiz 130-1.
Score: 0.052
-
Wolf JK, Franco EL, Arbeit JM, Shroyer KR, Wu TC, Runowicz CD, Tortolero-Luna G, Herrero R, Crum CP. Innovations in understanding the biology of cervical cancer. Cancer. 2003 Nov 01; 98(9 Suppl):2064-9.
Score: 0.047
-
Wu X, Tortolero-Luna G, Zhao H, Phatak D, Spitz MR, Follen M. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2003 Aug 15; 9(9):3356-61.
Score: 0.047